• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人群和倾向匹配队列研究:多学科风险评估和管理方案-糖尿病(RAMP-DM)对糖尿病相关并发症和卫生服务利用的 5 年效果。

Five-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) on Diabetes-Related Complications and Health Service Uses-A Population-Based and Propensity-Matched Cohort Study.

机构信息

Department of Family Medicine and Primary Care, Ap Lei Chau Clinic, Ap Lei Chau, The University of Hong Kong, Hong Kong, People's Republic of China

Department of Family Medicine and Primary Care, Ap Lei Chau Clinic, Ap Lei Chau, The University of Hong Kong, Hong Kong, People's Republic of China.

出版信息

Diabetes Care. 2018 Jan;41(1):49-59. doi: 10.2337/dc17-0426. Epub 2017 Nov 14.

DOI:10.2337/dc17-0426
PMID:29138274
Abstract

OBJECTIVE

To evaluate the 5-year effectiveness of a multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) in primary care patients with type 2 diabetes.

RESEARCH DESIGN AND METHODS

A 5-year prospective cohort study was conducted with 121,584 Chinese primary care patients with type 2 DM who were recruited between August 2009 and June 2011. Missing data were dealt with multiple imputations. After excluding patients with prior diabetes mellitus (DM)-related complications and one-to-one propensity score matching on all patient characteristics, 26,718 RAMP-DM participants and 26,718 matched usual care patients were followed up for a median time of 4.5 years. The effect of RAMP-DM on nine DM-related complications and all-cause mortality were evaluated using Cox regressions. The first incidence for each event was used for all models. Health service use was analyzed using negative binomial regressions. Subgroup analyses on different patient characteristics were performed.

RESULTS

The cumulative incidence of all events (DM-related complications and all-cause mortality) was 23.2% in the RAMP-DM group and 43.6% in the usual care group. RAMP-DM led to significantly greater reductions in cardiovascular disease (CVD) risk by 56.6% (95% CI 54.5, 58.6), microvascular complications by 11.9% (95% CI 7.0, 16.6), mortality by 66.1% (95% CI 64.3, 67.9), specialist attendance by 35.0% (95% CI 33.6, 36.4), emergency attendance by 41.2% (95% CI 39.8, 42.5), and hospitalizations by 58.5% (95% CI 57.2, 59.7). Patients with low baseline CVD risks benefitted the most from RAMP-DM, which decreased CVD and mortality risk by 60.4% (95% CI 51.8, 67.5) and 83.6% (95% CI 79.3, 87.0), respectively.

CONCLUSIONS

This naturalistic study highlighted the importance of early optimal DM control and risk factor management by risk stratification and multidisciplinary, protocol-driven, chronic disease model care to delay disease progression and prevent complications.

摘要

目的

评估多学科风险评估和管理计划-糖尿病(RAMP-DM)在基层医疗 2 型糖尿病患者中的 5 年效果。

研究设计和方法

这是一项前瞻性队列研究,纳入了 2009 年 8 月至 2011 年 6 月期间招募的 121584 名中国基层医疗 2 型糖尿病患者。对于缺失数据,采用多重插补法进行处理。在排除有糖尿病相关并发症史的患者以及对所有患者特征进行一对一倾向评分匹配后,对 26718 名 RAMP-DM 参与者和 26718 名匹配的常规护理患者进行了中位时间为 4.5 年的随访。使用 Cox 回归评估 RAMP-DM 对 9 种糖尿病相关并发症和全因死亡率的影响。所有模型均采用首次发生的事件作为因变量。采用负二项回归分析卫生服务利用情况。对不同患者特征进行亚组分析。

结果

RAMP-DM 组的全因事件(糖尿病相关并发症和全因死亡率)累积发生率为 23.2%,常规护理组为 43.6%。RAMP-DM 可显著降低心血管疾病(CVD)风险 56.6%(95%CI 54.5,58.6)、微血管并发症 11.9%(95%CI 7.0,16.6)、死亡率 66.1%(95%CI 64.3,67.9)、专科就诊率 35.0%(95%CI 33.6,36.4)、急诊就诊率 41.2%(95%CI 39.8,42.5)和住院率 58.5%(95%CI 57.2,59.7)。基线 CVD 风险较低的患者从 RAMP-DM 中获益最大,可降低 CVD 和死亡率风险分别达 60.4%(95%CI 51.8,67.5)和 83.6%(95%CI 79.3,87.0)。

结论

本项自然主义研究强调了通过风险分层和多学科、基于协议的慢性病管理模式进行早期优化糖尿病控制和危险因素管理的重要性,以延缓疾病进展和预防并发症。

相似文献

1
Five-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) on Diabetes-Related Complications and Health Service Uses-A Population-Based and Propensity-Matched Cohort Study.基于人群和倾向匹配队列研究:多学科风险评估和管理方案-糖尿病(RAMP-DM)对糖尿病相关并发症和卫生服务利用的 5 年效果。
Diabetes Care. 2018 Jan;41(1):49-59. doi: 10.2337/dc17-0426. Epub 2017 Nov 14.
2
Long-term effects of the multidisciplinary risk assessment and management program for patients with diabetes mellitus (RAMP-DM): a population-based cohort study.糖尿病患者多学科风险评估与管理项目(RAMP-DM)的长期影响:一项基于人群的队列研究。
Cardiovasc Diabetol. 2015 Aug 14;14:105. doi: 10.1186/s12933-015-0267-3.
3
Five-Year Cost-effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM).多学科风险评估和管理计划-糖尿病(RAMP-DM)的五年成本效益。
Diabetes Care. 2018 Feb;41(2):250-257. doi: 10.2337/dc17-1149. Epub 2017 Dec 15.
4
Ten-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) on Macrovascular and Microvascular Complications and All-Cause Mortality: A Population-Based Cohort Study.十年多学科风险评估和管理计划-糖尿病(RAMP-DM)对大血管和微血管并发症及全因死亡率的影响:一项基于人群的队列研究。
Diabetes Care. 2022 Dec 1;45(12):2871-2882. doi: 10.2337/dc22-0387.
5
Effects of the Multidisciplinary Risk Assessment and Management Program for Patients with Diabetes Mellitus (RAMP-DM) on biomedical outcomes, observed cardiovascular events and cardiovascular risks in primary care: a longitudinal comparative study.糖尿病患者多学科风险评估与管理项目(RAMP-DM)对基层医疗中生物医学结局、观察到的心血管事件及心血管风险的影响:一项纵向比较研究。
Cardiovasc Diabetol. 2014 Aug 21;13:127. doi: 10.1186/s12933-014-0127-6.
6
Effectiveness of the multidisciplinary Risk Assessment and Management Program for Patients with Diabetes Mellitus (RAMP-DM) for diabetic microvascular complications: A population-based cohort study.糖尿病微血管并发症多学科风险评估与管理项目(RAMP-DM)对糖尿病患者的有效性:一项基于人群的队列研究。
Diabetes Metab. 2016 Dec;42(6):424-432. doi: 10.1016/j.diabet.2016.07.030. Epub 2016 Aug 24.
7
Risk of Dementia Among Patients With Diabetes in a Multidisciplinary, Primary Care Management Program.多学科、初级保健管理计划中糖尿病患者的痴呆风险。
JAMA Netw Open. 2024 Feb 5;7(2):e2355733. doi: 10.1001/jamanetworkopen.2023.55733.
8
Five-year cost-effectiveness of the Patient Empowerment Programme (PEP) for type 2 diabetes mellitus in primary care.患者赋权计划(PEP)在初级保健中治疗 2 型糖尿病的 5 年成本效益分析。
Diabetes Obes Metab. 2017 Sep;19(9):1312-1316. doi: 10.1111/dom.12919. Epub 2017 May 5.
9
Effectiveness of a multidisciplinary risk assessment and management programme-diabetes mellitus (RAMP-DM) on patient-reported outcomes.多学科风险评估与管理项目——糖尿病(RAMP-DM)对患者报告结局的有效性。
Endocrine. 2017 Feb;55(2):416-426. doi: 10.1007/s12020-016-1124-1. Epub 2016 Oct 3.
10
Cost-effectiveness of a primary care multidisciplinary Risk Assessment and Management Program for patients with diabetes mellitus (RAMP-DM) over lifetime.糖尿病患者初级保健多学科风险评估和管理方案(RAMP-DM)的终生成本效益分析。
Endocrine. 2019 Feb;63(2):259-269. doi: 10.1007/s12020-018-1727-9. Epub 2018 Aug 28.

引用本文的文献

1
Influence of Diabetes Mellitus on Perioperative Outcomes Following Surgical Stabilization of Rib Fractures: A National Health Insurance Research Database Analysis.糖尿病对肋骨骨折手术固定术后围手术期结局的影响:一项国民健康保险研究数据库分析
Medicina (Kaunas). 2025 Jul 26;61(8):1358. doi: 10.3390/medicina61081358.
2
2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association.《2025年韩国糖尿病管理临床实践指南:韩国糖尿病协会的建议》
Diabetes Metab J. 2025 Jul;49(4):582-783. doi: 10.4093/dmj.2025.0469. Epub 2025 Jul 1.
3
Population risk stratification tools and interventions for chronic disease management in primary care: a systematic literature review.
基层医疗中慢性病管理的人群风险分层工具及干预措施:一项系统文献综述
BMC Health Serv Res. 2025 Apr 10;25(1):526. doi: 10.1186/s12913-025-12690-0.
4
A 30-year case study of local implementation of global guidelines for data-driven diabetes management starting with the Hong Kong Diabetes Register.一项为期30年的案例研究,该研究从香港糖尿病登记处开始,探讨全球数据驱动型糖尿病管理指南在当地的实施情况。
Lancet Reg Health West Pac. 2025 Mar 17;56:101505. doi: 10.1016/j.lanwpc.2025.101505. eCollection 2025 Mar.
5
Molecular Interaction Between Vasopressin and Insulin in Regulation of Metabolism: Impact on Cardiovascular and Metabolic Diseases.血管加压素与胰岛素在代谢调节中的分子相互作用:对心血管和代谢疾病的影响
Int J Mol Sci. 2024 Dec 11;25(24):13307. doi: 10.3390/ijms252413307.
6
ProtecT-2-D trial protocol: cardiovascular protection in patients with type 2 diabetes and established heart and/or vascular disease at a cardio-metabolic clinic-a randomized controlled trial.ProtecT-2-D 试验方案:在心脏代谢门诊对患有 2 型糖尿病和已确诊的心脏和/或血管疾病的患者进行心血管保护的随机对照试验。
Cardiovasc Diabetol. 2024 Jul 8;23(1):241. doi: 10.1186/s12933-024-02340-w.
7
Improving outcomes of type 2 diabetes mellitus patients in primary care with Chronic Care Model: A narrative review.采用慢性病照护模式改善基层医疗中2型糖尿病患者的治疗效果:一项叙述性综述。
J Gen Fam Med. 2024 May 20;25(4):171-178. doi: 10.1002/jgf2.659. eCollection 2024 Jul.
8
Intersectoral health interventions to improve the well-being of people living with type 2 diabetes: a scoping review protocol.跨部门卫生干预措施改善 2 型糖尿病患者的健康状况:系统评价方案。
BMJ Open. 2024 May 21;14(5):e080659. doi: 10.1136/bmjopen-2023-080659.
9
Cost-Savings Associated with Multi-Disciplinary Team Approach for Reducing Macrovascular and Microvascular Complications in Patients with Type 2 Diabetes: A Predictive Model.多学科团队方法在降低2型糖尿病患者大血管和微血管并发症方面的成本节约:一种预测模型
Clinicoecon Outcomes Res. 2024 Apr 4;16:211-223. doi: 10.2147/CEOR.S451739. eCollection 2024.
10
Traditional Chinese medicine could play an important role in diabetes management: Commentary on "National Chinese medicine guideline for the prevention and treatment of diabetes in primary care (2022)".中医在糖尿病管理中可发挥重要作用:评《基层糖尿病防治管理中医健康指导专家共识(2022年版)》
J Diabetes. 2024 Apr;16(4):e13532. doi: 10.1111/1753-0407.13532.